Development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies.
Michael Bigger is an investor and a trader who has been involved with trading technologies for more than twenty years. He runs the Bigger Capital Fund, LP and he manages money for many institutional investors.
Author, Market Technician at miAnalysis, Inc. I started my career in markets in 1999 and analyze stocks, ETFs, bonds, forex and commodities. Comments are not recommendations. Lucky husband, proud father. Future Ironman.
I construct charts to help people capitalize on the excess fear and greed of global investors.
My goal: provide research to help investors enlarge their portfolios regardless of market direction. My approach - TBNM or Tops, Bottoms, No Middles
Chicago Board Options Exchange (CBOE), the largest U.S. options exchange and creator of listed options, continues to set the bar for options trading through product innovation, trading technology and investor education.